June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.Unlock Stocks

Weight Loss Drugs Like Wegvoy and Zepbound Users - Nestlé Launches $5 Pizza For You

Published 21/05/2024, 19:25
© Reuters.  Weight Loss Drugs Like Wegvoy and Zepbound Users - Nestlé Launches $5 Pizza For You
LLY
-
NVO
-
NSRGF
-
NSRGY
-

Benzinga - by Vandana Singh, Benzinga Editor.

On Tuesday, Nestlé SA (OTC:NSRGF) (OTC:NSRGY) unveiled Vital Pursuit, a new line of foods designed to complement GLP-1 weight loss medications and aid consumers focused on weight management.

This comes amid fears among investors that food companies could see their sales suffer significantly.

Related: Changing Frugal Eating Habits – How Novo Nordisk/Eli Lilly’s Weight Loss Drugs Reshaping Food Spending.

The food and drink processing conglomerate says the new line includes protein, fiber, and essential nutrients, and it is portioned to accommodate the reduced appetite of weight loss medication users.

This line also supports a balanced diet for anyone on a weight management journey, marking Nestlé’s first venture into food products tailored specifically for GLP-1 users.

GLP-1 medications significantly influence how Americans manage weight, presenting a growing market opportunity.

Wegvoy and Ozempic (semaglutide) from Novo Nordisk A/S (NYSE:NVO) and Eli Lilly And Co’s (NYSE:LLY) Zepbound and Mounjaro (tirzepatide) have garnered tremendous fame as these “miracle” drugs have been shown to be effective at helping people lose weight by suppressing appetite.

According to the National Center of Health Statistics, nearly half of American adults attempt weight loss annually.

Moreover, in 2023, one in 60 adults was prescribed GLP-1 medications, with projections from the American Pharmacists Association indicating a rise in 2024.

J.P. Morgan Research forecasts that the number of GLP-1 users in the U.S. could reach 30 million by 2030, roughly 9% of the population.

Tom Moe, President of Nestlé USA Meals Division, noted that Nestlé aims to expand Vital Pursuit with more product formats as the market evolves.

Vital Pursuit will debut in Q4 with 12 SKUs, available at select retailers nationwide.

The product range includes frozen bowls with whole grains or protein pasta, sandwich melts, and pizzas, all priced at $4.99 and under.

These products are portioned for controlled eating and include essential nutrients like protein, vitamin A, potassium, calcium, or iron. Vital Pursuit also offers gluten-free and air-fryer-ready options for added convenience.

Read Next: Costco Long Known For Rotisserie Chicken And Hot Dogs Counters Junk Food With Weight Loss Plan To Help You Shed Those Extras.

Photo Via Shutterstock

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.